EE04952B1 - Ravimkoostis ja meetod selle valmistamiseks - Google Patents

Ravimkoostis ja meetod selle valmistamiseks

Info

Publication number: EE04952B1
Authority: EE; Estonia
Prior art keywords: pharmaceutical composition; preparation; active ingredient; additional active; stabilizers
Prior art date: 1999-07-28

Application number

EEP200200042A

Other languages

English (en)

Estonian (et)

Inventor

Vit βnyin� Morvai Magdolna

Kov βcs P�tern�

K βlm βnn� M βth� Irma

βrka Jakab Bogl

V�geli Erzs�bet

Original Assignee

Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy βra Rt.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-28

Filing date

2000-07-28

Publication date

2008-02-15

2000-07-28 Application filed by Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy βra Rt. filed Critical Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy βra Rt.

2003-04-15 Publication of EE200200042A publication Critical patent/EE200200042A/xx

2008-02-15 Publication of EE04952B1 publication Critical patent/EE04952B1/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 abstract 3
CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 abstract 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 1
OMFNSKIUKYOYRG-MOSHPQCFSA-N drotaverine Chemical compound C1=C(OCC)C(OCC)=CC=C1\C=C/1C2=CC(OCC)=C(OCC)C=C2CCN\1 OMFNSKIUKYOYRG-MOSHPQCFSA-N 0.000 abstract 1
OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
229960005489 paracetamol Drugs 0.000 abstract 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
229940069338 potassium sorbate Drugs 0.000 abstract 1
235000010241 potassium sorbate Nutrition 0.000 abstract 1
239000004302 potassium sorbate Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

EEP200200042A 1999-07-28 2000-07-28 Ravimkoostis ja meetod selle valmistamiseks EE04952B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU9902559A HU225779B1 (en)	1999-07-28	1999-07-28	Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
PCT/HU2000/000086 WO2001007024A2 (en)	1999-07-28	2000-07-28	Paracetamol and drotaverine containing composition

Publications (2)

Publication Number	Publication Date
EE200200042A EE200200042A (et)	2003-04-15
EE04952B1 true EE04952B1 (et)	2008-02-15

Family

ID=90014235

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200042A EE04952B1 (et)	1999-07-28	2000-07-28	Ravimkoostis ja meetod selle valmistamiseks

Country Status (19)

Country	Link
EP (1)	EP1200088B1 (de)
AT (1)	ATE241983T1 (de)
AU (1)	AU6308800A (de)
BG (1)	BG65553B1 (de)
DE (1)	DE60003188T2 (de)
DK (1)	DK1200088T3 (de)
EA (1)	EA003779B1 (de)
EE (1)	EE04952B1 (de)
ES (1)	ES2197107T3 (de)
GE (1)	GEP20053581B (de)
HR (1)	HRP20020071B1 (de)
HU (1)	HU225779B1 (de)
ME (2)	ME00088B (de)
PL (1)	PL197749B1 (de)
PT (1)	PT1200088E (de)
RS (1)	RS50074B (de)
SI (1)	SI1200088T1 (de)
UA (1)	UA72535C2 (de)
WO (1)	WO2001007024A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2232018C2 (ru) *	2002-10-09	2004-07-10	Открытое акционерное общество "Ирбитский химико-фармацевтический завод"	Спазмолитическое лекарственное средство
RU2252024C2 (ru) *	2003-04-22	2005-05-20	Гаврилов Андрей Станиславович	Способ получения спазмолитического лекарственного средства
UY29527A1 (es)	2005-05-13	2006-12-29	Schering Ag	Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
WO2016075617A1 (en) *	2014-11-11	2016-05-19	Dr. Reddys Laboratories Limited	Fixed dose pharmaceutical formulations of analgesic and anti-spasmodic drugs
EP3520781A1 (de) *	2018-02-05	2019-08-07	Adamed sp. z o.o.	Pharmazeutische zusammensetzung, umfassend metamizol, drotaverin und koffein
CA3174747A1 (en) *	2020-03-09	2021-09-16	Sushma Paul BERLIA	Controlled release formulations comprising drotaverine or salt thereof
CN115397411B (zh) *	2020-04-23	2025-08-22	浙江养生堂天然药物研究所有限公司	药物组合及其用途
BG113694A (bg)	2023-04-26	2024-10-31	"Адифарм" Еад	Фармацевтичен състав под формата на таблетка, съдържаща метамизол, кофеин и дротаверин и метод за нейното получаване

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3830353A1 (de) *	1988-09-07	1990-03-15	Basf Ag	Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US5348745A (en) *	1989-05-09	1994-09-20	Miles Inc.	Aqueous granulation solution and a method of tablet granulation

1999
- 1999-07-28 HU HU9902559A patent/HU225779B1/hu not_active IP Right Cessation
2000
- 2000-07-28 EA EA200200211A patent/EA003779B1/ru not_active IP Right Cessation
- 2000-07-28 AT AT00949829T patent/ATE241983T1/de active
- 2000-07-28 HR HR20020071A patent/HRP20020071B1/xx not_active IP Right Cessation
- 2000-07-28 PL PL353209A patent/PL197749B1/pl unknown
- 2000-07-28 ES ES00949829T patent/ES2197107T3/es not_active Expired - Lifetime
- 2000-07-28 DE DE60003188T patent/DE60003188T2/de not_active Expired - Lifetime
- 2000-07-28 EP EP00949829A patent/EP1200088B1/de not_active Expired - Lifetime
- 2000-07-28 SI SI200030163T patent/SI1200088T1/xx unknown
- 2000-07-28 RS YUP-61/02A patent/RS50074B/sr unknown
- 2000-07-28 EE EEP200200042A patent/EE04952B1/xx not_active IP Right Cessation
- 2000-07-28 WO PCT/HU2000/000086 patent/WO2001007024A2/en not_active Ceased
- 2000-07-28 AU AU63088/00A patent/AU6308800A/en not_active Abandoned
- 2000-07-28 DK DK00949829T patent/DK1200088T3/da active
- 2000-07-28 ME MEP-2008-185A patent/ME00088B/me unknown
- 2000-07-28 UA UA2002021475A patent/UA72535C2/uk unknown
- 2000-07-28 GE GE4754A patent/GEP20053581B/en unknown
- 2000-07-28 PT PT00949829T patent/PT1200088E/pt unknown
- 2000-07-28 ME MEP-185/08A patent/MEP18508A/xx unknown
2002
- 2002-01-30 BG BG106368A patent/BG65553B1/bg unknown

Also Published As

Publication number	Publication date
PL353209A1 (en)	2003-11-03
HRP20020071B1 (hr)	2011-01-31
WO2001007024A3 (en)	2001-03-29
MEP18508A (en)	2010-06-10
EP1200088A2 (de)	2002-05-02
RS50074B (sr)	2009-01-22
EP1200088B1 (de)	2003-06-04
EE200200042A (et)	2003-04-15
UA72535C2 (en)	2005-03-15
WO2001007024A2 (en)	2001-02-01
DK1200088T3 (da)	2003-09-22
PT1200088E (pt)	2003-10-31
ATE241983T1 (de)	2003-06-15
ME00088B (me)	2010-10-10
ES2197107T3 (es)	2004-01-01
HUP9902559A3 (en)	2003-05-28
EA200200211A1 (ru)	2002-08-29
YU6102A (sh)	2005-03-15
SI1200088T1 (en)	2003-12-31
HUP9902559D0 (en)	1999-10-28
HRP20020071A2 (en)	2003-12-31
AU6308800A (en)	2001-02-13
EA003779B1 (ru)	2003-08-28
GEP20053581B (en)	2005-07-25
DE60003188D1 (de)	2003-07-10
PL197749B1 (pl)	2008-04-30
HU225779B1 (en)	2007-08-28
BG65553B1 (bg)	2008-12-30
BG106368A (en)	2002-08-30
HUP9902559A2 (hu)	2002-04-29
DE60003188T2 (de)	2004-07-01

Similar Documents

Publication	Publication Date	Title
FI971776A0 (fi)	1997-04-25	Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
BR122012030846B8 (pt)	2021-05-25	composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e pelo menos um corticoesteróide, e, uso da mesma
EE201000018A (et)	2010-04-15	Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
EA200301275A1 (ru)	2004-06-24	Капсулы для ингаляции
BRPI0508579A (pt)	2007-08-14	composto, composição farmacêutica, e, uso de um composto
WO2004026836A8 (en)	2005-05-12	1-pyridin-4-yl-urea derivatives
WO2010019611A3 (en)	2010-04-15	Bridged polycyclic compound based compositions for topical and oral applications
EE200200042A (et)	2003-04-15	Ravimkoostis ja meetod selle valmistamiseks
MXPA04011990A (es)	2005-08-16	Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.
EA200702594A1 (ru)	2008-04-28	Многофункциональные композиции концентрата с высоким содержанием действующего вещества для контроля эктопаразитов
BR9912024A (pt)	2001-05-29	Emplastros em gel contento esteróide e processo para a produção dos mesmos
WO2002015933A3 (en)	2003-08-14	Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
IT8721538A0 (it)	1987-07-31	Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
BR0013283A (pt)	2002-04-23	Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
HRP20050342B1 (hr)	2013-11-08	Farmaceutska formulacija olanzapina
FI853228A7 (fi)	1986-02-25	Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.
NO20012673L (no)	2001-05-31	Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling
WO2004026319A3 (en)	2004-09-02	Pharmaceutical compositions increasing camp useful for the treatment of cancers
BR0313076A (pt)	2005-06-28	Sal de ácido orgânico de amlodipina
ATE321530T1 (de)	2006-04-15	Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
MXPA04006269A (es)	2004-09-27	Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
WO2002002763A3 (en)	2003-02-06	Recombinant staphylococcus aureus peptide deformylase
BR0215498A (pt)	2004-12-28	Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes
SI1677808T1 (sl)	2011-04-29	Kombiniran pripravek za zdravljenje sepse
WO2005056581A3 (en)	2005-10-13	Peptide able to specifically bind a chemokine receptor and use thereof

Legal Events

Date	Code	Title	Description
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2009-08-17	HC1A	Change of owner name	Owner name: CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYANRA ZRT
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2018-03-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20170728